Literature DB >> 1884328

Cystic fibrosis. Infection and immunity to Pseudomonas.

R U Sorensen1, R L Waller, J D Klinger.   

Abstract

Chronic pulmonary infection with P. aeruginosa in CF may result from: 1. An initial failure of clearance mechanisms (increased adherence) leading to the development of a highly compartmentalized inflammatory reaction; 2. Inhibition of clearing mechanisms for bacteria present in the bronchial lumen; and 3. A largely ineffective, and possibly damaging, hyperactivity of inflammatory cells in the lumen and bronchial wall. The special relationship between the CF host and P. aeruginos, always long-term, and frequently subtle in its complexity, needs further understanding in order to develop new strategies for the treatment of chronic lung infections with this organism.

Entities:  

Mesh:

Year:  1991        PMID: 1884328     DOI: 10.1007/bf02914534

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN: 0731-8235


  161 in total

1.  Antibody to multiple mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis, measured by an enzyme-linked immunosorbent assay.

Authors:  R S Baltimore; R B Fick; L Fino
Journal:  Pediatr Res       Date:  1986-11       Impact factor: 3.756

2.  In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing.

Authors:  R B Markham; G B Pier; J J Goellner; S B Mizel
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

3.  Phagocytosis of Candida albicans by alveolar macrophages from patients with cystic fibrosis.

Authors:  D O Sordelli; R J Cassino; C N Macri; M Kohan; M H Dillon; O H Pivetta
Journal:  Clin Immunol Immunopathol       Date:  1982-02

4.  Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients.

Authors:  K Komiyama; B F Habbick; S K Tumber
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

5.  Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study.

Authors:  W B Wheeler; M Williams; W J Matthews; H R Colten
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

6.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

7.  The etiology and persistence of cryptic bacterial infections: a hypothesis.

Authors:  J W Costerton
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

8.  Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection.

Authors:  G B Winnie; J D Klinger; J M Sherman; M J Thomassen
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine.

Authors:  J Nutman; M Berger; P A Chase; D G Dearborn; K M Miller; R L Waller; R U Sorensen
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

View more
  3 in total

1.  Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages.

Authors:  J Shellito; S Nelson; R U Sorensen
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Role of glutathione in immunity and inflammation in the lung.

Authors:  Pietro Ghezzi
Journal:  Int J Gen Med       Date:  2011-01-25

3.  Sitagliptin Inhibits Extracellular Matrix Accumulation and Proliferation in Lung Fibroblasts.

Authors:  Xiuwu Liu; Tao Zhang; Chengcai Zhang
Journal:  Med Sci Monit       Date:  2020-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.